# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Christopher Reeve (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML024-SYN-TD
- Date: 2003-08-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Teresa Galloway, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-month review: kidney function, skin, mood, and equipment. **S**

## History of present illness

Mr. Reeve returns two months after his last review. He now uses the pacer for three hours twice a day. The seating service saw him three weeks ago through a second provider: pressure mapping showed higher pressure under the left sitting bone, and his cushion was adjusted; repeat mapping after the change was even. His skin has stayed intact. He has had no symptoms of autonomic dysreflexia, and his bladder and bowel programs are working. His mood is good and he is busy with his advocacy work. **S**

| Element | Detail |
|---|---|
| Breathing | Pacer three hours twice a day |
| Seating | Pressure mapping done; cushion adjusted for higher left ischial pressure |
| Skin | Intact |
| Mood | Good; PHQ-9 2 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No fever or change in secretions |
| Cardiovascular | Negative | No pounding headaches or flushing; no leg swelling |
| Genitourinary | Negative | Catheter draining well |
| Integumentary | Negative | No lasting redness |
| Psychiatric | Negative | Mood good |

5 systems reviewed. **S**

## Current medications

- Sennosides 8.6 mg oral tablet, two tablets at bedtime **S**
- Nitroglycerin 2% ointment, one inch to the skin of the chest only if systolic blood pressure stays at 150 mmHg or higher after the first steps of the autonomic dysreflexia plan; wipe off when pressure falls **S**
- Acetaminophen 500 mg oral tablet, two tablets up to three times a day as needed for neck and shoulder aching **S**
- Cholecalciferol (vitamin D3) 1977 units (50 mcg) oral capsule, one capsule daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/66 mmHg; pulse 62 bpm; respirations 12/min; temperature 36.4 °C; oxygen saturation 97% on his home ventilator settings via tracheostomy, no supplemental oxygen; weight 82.8 kg; BMI 22.2 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.5 mg/dL (low); Cystatin C: 0.9 mg/L; eGFR (cystatin C): 93 mL/min/1.73 m²; Braden scale: 12; PHQ-9: 2. All results are synthetic.

## Change since baseline

- Sodium: 138 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 4.3 mmol/L at this visit **S**
- Creatinine: 0.48 mg/dL (low) at baseline, 0.5 mg/dL (low) at this visit **S**
- Cystatin C: 0.92 mg/L at baseline, 0.9 mg/L at this visit **S**
- eGFR (cystatin C): 90 mL/min/1.73 m² at baseline, 93 mL/min/1.73 m² at this visit **S**
- Braden scale: 11 at baseline, 12 at this visit **S**
- PHQ-9: 3 at baseline, 2 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 104/66, pulse 62 |
| Respiratory | On the pacer with saturation 97%; clear |
| Skin | Intact, including the left ischium; Braden score 12 |
| Extremities | No leg swelling |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Chronic incomplete C2 tetraplegia** (G82.52). Seating review completed and the cushion adjusted; skin intact; no autonomic dysreflexia; PHQ-9 2. **S**
   - Continue the current skin, seating and autonomic dysreflexia plans.
2. **Neurogenic bladder with an indwelling catheter** (N31.9). Cystatin C 0.90 mg/L, eGFR 93: stable kidney function. **S**
   - Continue catheter care.
3. **Ventilator dependence with diaphragm pacing** (Z99.11). Three hours twice a day on the pacer, his six-month goal reached early. **S**
   - Hold at this level through the autumn and review further step-up with Dr. Kovac.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Autonomic dysreflexia: episodes, baseline blood pressure, written plan, and nurse training | Every visit | Completed today | No episodes |
| Survey | Skin check and Braden scale | Every visit | Completed today | Intact; Braden 12 |
| Self-management | Seating, cushion, and pressure mapping | At least yearly and after any change in equipment, weight or skin | Completed today | Pressure mapping done three weeks ago through a second provider; cushion adjusted for higher left ischial pressure; repeat mapping even |
| Self-management | Catheter care and urinary symptoms | Every visit | Completed today | No symptoms |
| Laboratory | Kidney function (cystatin C; creatinine unreliable with low muscle mass) | At baseline, then every 6 to 12 months | Completed today | Cystatin C 0.90 mg/L, eGFR 93; sodium 139, potassium 4.3 mmol/L; creatinine 0.50 mg/dL |
| Self-management | Bowel program | Every visit | Completed today | Effective |
| Examination | Pacer conditioning, oxygen saturation, and secretion clearance | Every visit | Completed today | Pacer three hours twice a day; saturation 97% on the pacer |
| Self-management | Backup ventilator, suction, cough-assist device, and power plan | Every visit, with monthly checks by his nurses | Completed today | Checks up to date; generator serviced |
| Survey | Depression screen (PHQ-9) | At intake, then every 6 to 12 months and with any change | Completed today | PHQ-9 2 |
| Examination | Venous thromboembolism: leg swelling | Every visit; prophylaxis only during acute illness, surgery or immobilization | Completed today | No leg swelling |

## Goal progress

- Lengthen time on the diaphragm pacer to at least three hours twice a day by six months, with stable oxygen saturation. In progress; target 2003-10-26. **S**
- No pressure injury: skin intact at every check through six months. In progress; target 2003-10-26. **S**
- Written autonomic dysreflexia plan held by him and every nurse, with all nurses trained, by the two-week visit. Outcome by 2003-04-27: Plan and wallet card in place; all regular nurses trained. **S**
- 25-hydroxyvitamin D at least 30 ng/mL within three months. Outcome by 2003-06-22: 34 ng/mL at ten weeks. **S**
- No unplanned hospital admission through six months. In progress; target 2003-10-26. **S**

## Guideline basis

- Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Pressure Ulcer Prevention and Treatment Following Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers, Second Edition (Consortium for Spinal Cord Medicine) (2014), Paralyzed Veterans of America
- Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers (Consortium for Spinal Cord Medicine) (2006), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up (2021), American Urological Association and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (Journal of Urology)
- Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Respiratory management following spinal cord injury: a clinical practice guideline for health-care professionals (Consortium for Spinal Cord Medicine) (2005), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed. (Consortium for Spinal Cord Medicine) (2016), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)

## Follow-up

- Preventive visit in three weeks for vaccines. Six-month review in two months. **S**
- Next scheduled visit 2003-09-14: periodic adult preventive visit. **S**
